Churchill Downs Incorporated and NBC Sports Extend Historic Partnership
LOUISVILLE, Ky., May 04, 2024 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN) (“CDI”) announced today that NBC Sports will […]
Mystik Dan Wins the Historic 150th Running of the Kentucky Derby Presented by Woodford Reserve
LOUISVILLE, Ky., May 04, 2024 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN) (the “Company”, “CDI”) announced today that a […]
Thorpedo Anna Claims the Lilies for the 150th Running of the Longines Kentucky Oaks
LOUISVILLE, KY., May 03, 2024 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN) (the “Company”, “CDI”, “we”) announced a new […]
Canoo to Announce First Quarter 2024 Financial Results
Justin, TX, May 03, 2024 (GLOBE NEWSWIRE) — Canoo Inc. (Nasdaq: GOEV), a high-tech advanced mobility company, today announced that […]
LGI Homes, Inc. Reports April 2024 Home Closings
THE WOODLANDS, Texas, May 03, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 505 homes […]
American Oncology Network Announces CFO Transition
FORT MYERS, Fla., May 03, 2024 (GLOBE NEWSWIRE) — American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly […]
Newbury Street Acquisition Corporation Announces Receipt of Nasdaq Letter
Boston, MA, May 03, 2024 (GLOBE NEWSWIRE) — Newbury Street Acquisition Corporation (NASDAQ: NBST, the “Company”) announced today that it […]
Compass Pathways to announce first quarter financial results on May 8, 2024
LONDON, May 03, 2024 (GLOBE NEWSWIRE) — Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access […]
Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions
CUPERTINO, Calif., May 03, 2024 (GLOBE NEWSWIRE) — Apple Inc. has released the following notice: A Federal Court authorized this […]
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and […]
